Visibly improves dryness, dullness, and uneven skin tone
This direct activation of a critical angiogenic pathway, independent of VEGF-A expression, highlights a unique aspect of BPC-157's regenerative capacity
Reported side effects (minimal) Most users report zero side effects - Epithalon remarkably well-tolerated Occasional reported effects: Mild injection site reactions (redness, slight swelling) Temporary headache (first 1-2 days) Slight drowsiness initially (adjusting to improved sleep ) Vivid dreams (from enhanced melatonin ) Increased appetite in some (rare) What Epithalon does NOT typically cause: No nausea (unlike GLP-1 agonists ) No GI upset No hormonal disruption No mood changes (may improve mood) No dependency or withdrawal Side effect comparison: Managing minor side effects: Headache: Hydrate well, usually resolves day 2-3 Drowsiness: Inject at bedtime instead of morning Vivid dreams: Enjoy them or reduce dose slightly Injection reactions : Rotate sites, ice after injection See our peptide safety and risks guide and common peptide mistakes to avoid
One of our experts will meet with you to discuss your symptoms and evaluate your potential treatment area
This is particularly concerning in the context of plantar fasciitis, where the plantar fascia itself could be weakened, potentially worsening the condition
